Profile of Vaccine Research: A Bibliometric Analysis

Overview

Journal Hum Vaccin Immunother

Date 2025 Feb 5

PMID 39906958

Authors

Xuemei Wang

Qian Wang

Yidan Gao

Lijuan Jiang

Lingli Tang

Affiliations

Soon will be listed here.

Abstract

Vaccination is the most effective measure to prevent infection. However, to date, no vaccine has successfully completed the rigorous clinical trial process and gained regulatory approval for use in clinical practice. Scholars have been working on a safe and effective vaccine. In order to better grasp, the global frontiers and development trends in this field, a comprehensive bibliometric analysis was carried out. A total of 234 publications closely regarding vaccines were culled from the Web of Science Core Collection database, and the bibliometric information was then extracted with CiteSpace and VOSviewer software. After measurement analysis, the most influential papers were identified in this area, including highly cited papers, references with strong citation burst, and high co-citated papers. has published the most literature on vaccines. Only scholars from 39 countries/regions have been engaged in studying vaccines. The USA is the most prolific country and has the highest collaborative strength. The current research area has focused on protective immunity and immunopathological response. Major outer membrane protein (MOMP) is the most common target vaccine antigen. This study reveals the status of literature and highlights emerging trends in this field, which helps researchers seek insights into this area and serve as a reference guide for further investigations.

References

Rockey D, Wang J, Lei L, Zhong G . Chlamydia vaccine candidates and tools for chlamydial antigen discovery. Expert Rev Vaccines. 2009; 8(10):1365-77. DOI: 10.1586/erv.09.98. View

Longbottom D, Livingstone M . Vaccination against chlamydial infections of man and animals. Vet J. 2006; 171(2):263-75. DOI: 10.1016/j.tvjl.2004.09.006. View

Ninkov A, Frank J, Maggio L . Bibliometrics: Methods for studying academic publishing. Perspect Med Educ. 2021; 11(3):173-176. PMC: 9240160. DOI: 10.1007/s40037-021-00695-4. View

Li Y, Zheng K, Tan Y, Wen Y, Wang C, Chen Q . A recombinant multi-epitope peptide vaccine based on MOMP and CPSIT_p6 protein protects against Chlamydia psittaci lung infection. Appl Microbiol Biotechnol. 2018; 103(2):941-952. DOI: 10.1007/s00253-018-9513-4. View

Webster E, Seiger K, Core S, Collar A, Knapp-Broas H, Graham J . Immunogenicity and Protective Capacity of a Virus-like Particle Vaccine against Type 3 Secretion System Tip Protein, CT584. Vaccines (Basel). 2022; 10(1). PMC: 8779370. DOI: 10.3390/vaccines10010111. View

Li Y, Wang C, Sun Z, Xiao J, Yan X, Chen Y . Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles-Adjuvanted Vaccine Elicits Elevated Protective Responses In The Lung. Int J Nanomedicine. 2019; 14:8179-8193. PMC: 6790120. DOI: 10.2147/IJN.S218456. View

Brunham R . Problems With Understanding Chlamydia trachomatis Immunology. J Infect Dis. 2021; 225(11):2043-2049. DOI: 10.1093/infdis/jiab610. View

Guo X, Pan X, Sun Q, Hu Y, Shi J . Design of a novel multiepitope vaccine against Chlamydia pneumoniae using the extracellular protein as a target. Sci Rep. 2023; 13(1):15070. PMC: 10497608. DOI: 10.1038/s41598-023-42222-x. View

Crane D, Carlson J, Fischer E, Bavoil P, Hsia R, Tan C . Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc Natl Acad Sci U S A. 2006; 103(6):1894-9. PMC: 1413641. DOI: 10.1073/pnas.0508983103. View

10.

Wang C, Jin Y, Wang J, Zheng K, Lei A, Lu C . Protective Immunity against Lung Infection Induced by a DNA Plasmid Vaccine Carrying Gene Inhibits Dissemination in BALB/c Mice. Int J Mol Sci. 2023; 24(8). PMC: 10138700. DOI: 10.3390/ijms24087013. View

11.

de la Maza L, Zhong G, Brunham R . Update on Chlamydia trachomatis Vaccinology. Clin Vaccine Immunol. 2017; 24(4). PMC: 5382834. DOI: 10.1128/CVI.00543-16. View

12.

Tian Q, Zhang T, Shu C, Han Z, Huang Y, Wan J . Diverse animal models for infections: unraveling pathogenesis through the genital and gastrointestinal tracts. Front Microbiol. 2024; 15:1386343. PMC: 11007077. DOI: 10.3389/fmicb.2024.1386343. View

13.

Elwell C, Mirrashidi K, Engel J . Chlamydia cell biology and pathogenesis. Nat Rev Microbiol. 2016; 14(6):385-400. PMC: 4886739. DOI: 10.1038/nrmicro.2016.30. View

14.

Ji Y, Ma X, Li Z, Peppelenbosch M, Ma Z, Pan Q . The Burden of Human Papillomavirus and Chlamydia trachomatis Coinfection in Women: A Large Cohort Study in Inner Mongolia, China. J Infect Dis. 2018; 219(2):206-214. DOI: 10.1093/infdis/jiy497. View

15.

Gottlieb S, Spielman E, Abu-Raddad L, Aderoba A, Bachmann L, Blondeel K . WHO global research priorities for sexually transmitted infections. Lancet Glob Health. 2024; 12(9):e1544-e1551. PMC: 11342064. DOI: 10.1016/S2214-109X(24)00266-3. View

16.

Liang S, Bulir D, Kaushic C, Mahony J . Considerations for the rational design of a Chlamydia vaccine. Hum Vaccin Immunother. 2016; 13(4):831-835. PMC: 5404357. DOI: 10.1080/21645515.2016.1252886. View

17.

Blakney A, McKay P, Christensen D, Yus B, Aldon Y, Follmann F . Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA. J Control Release. 2019; 304:65-74. DOI: 10.1016/j.jconrel.2019.04.043. View

18.

Pollock K, Borges A, Cheeseman H, Rosenkrands I, Schmidt K, Sondergaard R . An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial. Lancet Infect Dis. 2024; 24(8):829-844. DOI: 10.1016/S1473-3099(24)00147-6. View

19.

Rashid A, Li K, Feng Y, Ahmad T, Getaneh Y, Yu Y . HIV-1 genetic diversity a challenge for AIDS vaccine development: a retrospective bibliometric analysis. Hum Vaccin Immunother. 2022; 18(1):2014733. PMC: 8973384. DOI: 10.1080/21645515.2021.2014733. View

20.

Phillips S, Quigley B, Timms P . Seventy Years of Vaccine Research - Limitations of the Past and Directions for the Future. Front Microbiol. 2019; 10:70. PMC: 6365973. DOI: 10.3389/fmicb.2019.00070. View